Mannkind logo

Mannkind Share Price (NASDAQ: MNKD)

$3.73

0.03

(0.81%)

Live

Last updated on

Check the interactive Mannkind Stock chart to analyse performance

Mannkind stock performance

as on August 16, 2025 at 12:36 AM IST

  • Today's Low:$3.70
    Today's High:$3.74

    Day's Volatility :1.07%

  • 52 Weeks Low:$3.38
    52 Weeks High:$7.63

    52 Weeks Volatility :55.69%

Mannkind Stock Returns

PeriodMannkind Corp.Sector (Health Care)Index (Russel 2000)
3 Months
-15.22%
2.7%
0.0%
6 Months
-31.64%
-7.5%
0.0%
1 Year
-28.61%
-12.3%
0.0%
3 Years
-6.44%
-0.3%
-12.5%

Mannkind Corp. Key Stats

Check Mannkind key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.7
Open
$3.66
Today's High
$3.74
Today's Low
$3.7
Market Capitalization
$1.0B
Today's Volume
$2.2M
52 Week High
$7.63
52 Week Low
$3.3812
Revenue TTM
$301.7M
EBITDA
$81.2M
Earnings Per Share (EPS)
$0.11
PE Ratio
31.09
Profit Margin
10.87%
Quarterly Earnings Growth YOY
0.09%
Return On Equity TTM
0.0%

Stock Returns calculator for Mannkind Stock including INR - Dollar returns

The Mannkind stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mannkind investment value today

Current value as on today

₹76,124

Returns

₹23,876

(-23.88%)

Returns from Mannkind Stock

₹28,131 (-28.13%)

Dollar Returns*

₹4,255 (+4.26%)

Indian investors sentiment towards Mannkind Stock

45%

Period: Jul 15, 2025 to Aug 14, 2025. Change in 30 Days versus previous period

Search interest for Mannkind Stock from India on INDmoney has increased by 45% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mannkind Corp.

  • Name

    Holdings %

  • BlackRock Inc

    7.98%

  • Vanguard Group Inc

    5.65%

  • State Street Corp

    3.09%

  • venBio Select Advisor LLC

    2.85%

  • Nitorum Capital, L.P.

    2.54%

  • Geode Capital Management, LLC

    2.21%

Analyst Recommendation on Mannkind Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Mannkind(by analysts ranked 0 to 5 stars)

Mannkind Share Price Target

What analysts predicted

Upside of 147.99%

Target:

$9.25

Current:

$3.73

Mannkind share price target is $9.25, a slight Upside of 147.99% compared to current price of $3.73 as per analysts' prediction.

Mannkind Stock Insights

  • Price Movement

    In the last 3 months, MNKD stock has moved down by -18.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 78.35M → 76.52M (in $), with an average decrease of 2.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 13.15M → 668.0K (in $), with an average decrease of 94.9% per quarter
  • MNKD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.5% return, outperforming this stock by 97.1%
  • MNKD vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.6% return, outperforming this stock by 100.6%
  • Price to Sales

    ForMNKD every $1 of sales, investors are willing to pay $3.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.3 for every $1 of sales.

Mannkind Corp. Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$285.5M
↑ 43.5%
Net Income
$27.6M
↓ 331.09%
Net Profit Margin
9.66%
↑ 15.66%

Mannkind Technicals Summary

Sell

Neutral

Buy

Mannkind is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mannkind Corp. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Mannkind Corp. logo
-6.44%
-31.64%
-28.61%
-6.44%
110.51%
Regeneron Pharmaceuticals, Inc. logo
3.34%
-15.94%
-51.82%
-12.71%
-8.78%
Beone Medicines Ltd logo
10.04%
33.07%
60.93%
63.19%
37.46%
Vertex Pharmaceuticals Incorporated logo
-16.76%
-14.85%
-17.19%
28.99%
42.73%
Alnylam Pharmaceuticals, Inc. logo
37.12%
72.6%
68.49%
94.01%
214.59%

About Mannkind Corp.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension. The company's product pipeline includes MNKD-101, a nebulized formulation of clofazimine, which is in Phase 3 study, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, which is in phase 1 clinical study, for the treatment of idiopathic pulmonary fibrosis (IPF); MNKD-301, which is in preclinical stage, for cystic fibrosis; and Pediatric Afrezza, which is in phase 3 clinical trial for the treatment of diabetes mellitus. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India; and co-promotion agreement with Amphastar for marketing of Baqsimi (glucagon) nasal powder. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
Organization
Mannkind
Employees
403
CEO
Dr. Michael E. Castagna Pharm.D.
Industry
Health Technology

Key Management of Mannkind Corp.

NameTitle
Dr. Michael E. Castagna Pharm.D.
CEO & Director
Mr. Christopher B. Prentiss M.B.A.
Chief Financial Officer
Dr. David B. Thomson J.D., Ph.D.
Executive VP, General Counsel & Secretary
Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
Ms. Rosabel Realica Alinaya CPA
VP of Investor Relations & Treasury
Dr. Stuart A. Tross Ph.D.
Executive Vice President of Human Resources
Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
Dr. Kevin Kaiserman M.D.
Senior VP & Therapeutic Area Head of Endocrine Diseases
Mr. Dominic Marasco R.Ph.
President of Endocrine Business Unit

Important FAQs about investing in MNKD Stock from India :

What is Mannkind share price today?

Mannkind share price today is $3.73 as on . Mannkind share today touched a day high of $3.74 and a low of $3.70.

What is the 52 week high and 52 week low for Mannkind share?

Mannkind share touched a 52 week high of $7.63 and a 52 week low of $3.38. Mannkind stock price today, is trending at $3.73, lower by 51.11% versus the 52 week high.

How to invest in Mannkind Stock (MNKD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mannkind on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mannkind Shares that will get you 0.4021 shares as per Mannkind share price of $3.73 per share as on August 16, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Mannkind Stock (MNKD) from India?

Indian investors can start investing in Mannkind (MNKD) shares with as little as ₹87.492 or $1 (as of August 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Mannkind stock (as per the Rupee-Dollar exchange rate as on August 15, 2025). Based on Mannkind share’s latest price of $3.73 as on August 16, 2025 at 12:36 AM IST, you will get 2.6810 shares of Mannkind. Learn more about fractional shares .

What are the returns that Mannkind has given to Indian investors in the last 5 years?

Mannkind stock has given 110.51% share price returns and 16.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?